text
"['\n2. 연결재무제표\n가. 연결재무상태표\n분 기 연 결 재 무 상 태 표\n\xa0제 75 기 \xa01분기 : \xa02023년 03월 31일 현재\n\xa0제 74 기 \xa0 \xa0 \xa0 \xa0 \xa0 : \xa02022년 12월 31일 현재\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 목\n주 \xa0석\n제 75(당)기 1분기말\n제 74(전)기말\n자 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0산\n\u3000\n\xa01. 현금및상각후원가측정예치금\n5,6,7\n4,285,337,725,747\n4,776,589,231,248\n\xa0 \xa01). 현금및현금성자산\n1,909,247,393,234\n2,908,267,355,517\n\xa0 \xa02). 상각후원가측정예치금\n2,376,090,332,513\n\u3000-\n\xa0 \xa03). 예치금\n-\n1,868,321,875,731\n\xa02. 당기손익-공정가치측정금융자산\n5,6,8\n54,371,913,472,518\n-\n\xa03. 당기손익-인식유가증권\n5,6,8\n-\n30,044,783,287,672\n\xa04. 기타포괄손익공정가치측정유가증권\n5,6,9\n42,419,515,363,840\n-\n\xa05. 매도가능유가증권\n5,6,9\n-\n42,496,677,563,459\n\xa06. 상각후원가측정유가증권\n5,6,10\n11,837,658,197,936\n-\n\xa07. 만기보유유가증권\n5,6,10\n-\n32,314,845,458,197\n\xa08. 상각후원가측정대출채권및수취채권\n14,35\n23,845,157,069,576\n-\n\xa09. 대출채권\n14,35\n-\n25,960,037,682,416\n\xa010. 파생상품자산\n5,6,16\n614,508,997,116\n1,007,942,283,352\n\xa011. 보험계약자산\xa0\n21\n86,008,370\n10,373,554,196\n\xa012. 재보험계약자산\n21\n836,987,890,844\n767,032,241,977\n\xa013. 종속기업및관계기업에대한투자자산\n12,13\n500,187,219,920\n580,815,564,796\n\xa014. 유형자산\n18\n1,604,085,639,371\n1,633,756,720,819\n\xa015. 투자부동산\n18\n2,734,458,575,757\n2,701,395,486,370\n\xa016. 무형자산\n18\n530,750,558,194\n1,115,180,026,541\n\xa017. 순확정급여자산\n24\n(9,087,042,230)\n106,306,313,003\n\xa018. 사용권자산\n18\n201,820,739,590\n170,393,615,433\n\xa019. 당기법인세자산\n34\n191,984,171,270\n236,492,112,973\n\xa020. 이연법인세자산\n34\n8,086,790,102\n10,330,738,655\n\xa021. 기타금융자산\n15\n2,702,044,810,667\n2,082,563,281,795\n\xa022. 기타자산\n20\n251,464,090,041\n603,796,639,787\n자 \xa0 산 \xa0 총 \xa0 계\n146,926,960,278,629\n146,619,311,802,689\n부 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0채\n\xa01. 보험계약부채\n21\n100,654,454,756,662\n97,281,828,647,068\n\xa02. 재보험계약부채\n21\n66,428,939,300\n48,177,485,996\n\xa03. 기타계약부채\n21\n8,088,615,793,680\n8,238,039,605,474\n\xa04. 당기손익-공정가치측정금융부채\n22\n3,202,148,939,719\n2,769,309,754,587\n\xa05. 차입부채\n23\n10,372,433,968,213\n9,848,429,543,178\n\xa06. 파생상품부채\n16\n2,188,605,860,030\n2,306,815,076,420\n\xa07. 충당부채\n25\n95,517,431,739\n125,570,590,132\n\xa08. 기타금융부채\n26\n4,183,051,282,714\n2,920,737,526,334\n\xa09 .당기법인세부채\n34\n73,596,693,905\n124,677,684,203\n\xa010. 이연법인세부채\n34\n1,265,224,957,277\n2,489,975,928,643\n\xa011. 순확정급여부채\n24\n223,999,055,726\n326,884,499,257\n\xa012. 기타부채\n27\n160,817,641,951\n85,056,779,381\n부 \xa0 채 \xa0 총 \xa0 계\n130,574,895,320,916\n126,565,503,120,673\n자 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0본\n\xa01. 자본금\n28\n4,342,650,000,000\n4,342,650,000,000\n\xa02. 기타불입자본\n28\n(8,419,708,343)\n3,010,079,475\n\xa03. 신종자본증권\n29\n1,558,370,079,138\n1,558,370,079,138\n\xa04. 기타자본구성요소\n30\n1,201,318,313,465\n4,471,921,069,548\n\xa05. 이익잉여금\n31\n6,821,286,413,770\n8,440,142,034,324\n\xa06. 비지배지분당기순이익\n38\n2,436,859,859,683\xa0\n1,237,715,419,531\xa0\n자 \xa0 본 \xa0 총 \xa0 계\n16,352,064,957,713\xa0\n20,053,808,682,016\xa0\n부 채 와 자 본 총 계\n146,926,960,278,629\xa0\n146,619,311,802,689\xa0\n나. 연결포괄손익계산서\n\xa0분 기 연 결 포 괄 손 익 계 산 서\n제 75기 1분기 : 2023년 1월 1일부터 2023년 03월 31일까지\n제 74 기 1분기 : 2022년 1월 1일부터 2022년 03월 31일까지\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0목\n주 석\n제 75(당) 1분기\n제 74(전) 1분기\n\xa0Ⅰ. \xa0보험영업손익\n21,35\n\u3000\n258,481,983,813\xa0\n\u3000\n418,096,221,576\xa0\n\xa0 \xa01. \xa0보험영업손익\n265,680,070,094\xa0\n\u3000\n456,121,211,664\xa0\n\u3000\n\xa0 \xa0 \xa01) \xa0보험영업수익\n2,296,498,483,367\xa0\n\u3000\n2,157,255,237,320\xa0\n\u3000\n\xa0 \xa0 \xa02) \xa0보험서비스비용\n2,030,818,413,273\xa0\n\u3000\n1,701,134,025,656\xa0\n\u3000\n\xa0 \xa02. \xa0출재보험손익\n(7,198,086,281)\n\u3000\n(38,024,990,088)\n\u3000\n\xa0 \xa0 \xa01) \xa0출재보험수익\n169,551,573,085\xa0\n\u3000\n142,949,963,573\xa0\n\u3000\n\xa0 \xa0 \xa02) \xa0출재보험비용\n176,749,659,366\xa0\n\u3000\n180,974,953,661\xa0\n\u3000\n\xa0Ⅱ. \xa0투자영업손익\n21,35\n\u3000\n2,158,502,199,469\xa0\n\u3000\n180,402,776,186\xa0\n\xa0 \xa01. \xa0투자영업수익\n4,945,834,697,088\xa0\n\u3000\n2,657,473,669,544\xa0\n\u3000\n\xa0 \xa0 \xa01) \xa0이자수익\n888,961,802,907\xa0\n\u3000\n793,440,682,666\xa0\n\u3000\n\xa0 \xa0 \xa02) \xa0배당수익\n72,377,184,663\xa0\n\u3000\n250,684,325,949\xa0\n\u3000\n\xa0 \xa0 \xa03) \xa0임대료수익\n34,916,416,604\xa0\n\u3000\n37,181,808,932\xa0\n\u3000\n\xa0 \xa0 \xa04) \xa0당기손익인식-공정가치금융자산관련이익\n1,583,587,912,682\xa0\n\u3000\n-\n\u3000\n\xa0 \xa0 \xa05) \xa0당기손익인식유가증권 평가 및 처분이익\n-\n\u3000\n326,587,093,088\xa0\n\u3000\n\xa0 \xa0 \xa06) \xa0기타포괄손익-공정가치금융자산관련이익\n3,947,449,754\xa0\n\u3000\n-\n\u3000\n\xa0 \xa0 \xa07) \xa0매도가능유가증권 평가 및 처분이익\n-\n\u3000\n133,108,584,128\xa0\n\u3000\n\xa0 \xa0 \xa08) 상각후원가측정금융자산 관련 이익\n1,161,561,363\xa0\n\u3000\n-\n\u3000\n\xa0 \xa0 \xa09) \xa0외환거래 및 환산이익\n995,537,305,123\xa0\n\u3000\n518,077,106,040\xa0\n\u3000\n\xa0 \xa0 \xa010) \xa0파생상품평가 및 거래이익\n1,100,081,396,979\xa0\n\u3000\n448,724,346,453\xa0\n\u3000\n\xa0 \xa0 \xa011) \xa0기타투자수익\n265,263,667,013\xa0\n\u3000\n149,669,722,288\xa0\n\u3000\n\xa0 \xa02. \xa0투자영업비용\n2,787,332,497,619\xa0\n\u3000\n2,477,070,893,358\xa0\n\u3000\n\xa0 \xa0 \xa01) \xa0이자비용\n114,855,294,178\xa0\n\u3000\n106,734,877,368\xa0\n\u3000\n\xa0 \xa0 \xa02) \xa0재산관리비\n12,864,371,224\xa0\n\u3000\n5,893,598,148\xa0\n\u3000\n\xa0 \xa0 \xa03) \xa0당기손익인식공정가치측정금융자산 관련 손실\n486,045,736,131\xa0\n\u3000\n-\n\u3000\n\xa0 \xa0 \xa04) \xa0당기손익인식유가증권 평가 및 처분손실\n-\n\u3000\n1,006,363,699,847\xa0\n\u3000\n\xa0 \xa0 \xa05) \xa0기타포괄손익공정가치측정금융자산 관련 손실\n5,738,254,408\xa0\n\u3000\n-\n\u3000\n\xa0 \xa0 \xa06) \xa0매도가능유가증권 평가 및 처분손실\n-\n\u3000\n41,840,647,230\xa0\n\u3000\n\xa0 \xa0 \xa07) \xa0상각후원가측정금융자산 관련 손실\n28,162,479,147\xa0\n\u3000\n-\n\u3000\n\xa0 \xa0 \xa08) \xa0대출채권 및 수취채권 평가 및 처분 손실\n-\n\u3000\n10,896,366,636\xa0\n\u3000\n\xa0 \xa0 \xa09) \xa0외환거래 및 환산손실\n266,934,209,825\xa0\n\u3000\n130,266,817,935\xa0\n\u3000\n\xa0 \xa0 \xa010) \xa0파생상품평가 및 거래손실\n1,620,566,290,719\xa0\n\u3000\n1,031,751,269,132\xa0\n\u3000\n\xa0 \xa0 \xa011) \xa0기타투자비용\n252,165,861,987\xa0\n\u3000\n143,323,617,062\xa0\n\u3000\n\xa0Ⅲ. 보험금융손익\n21\n\u3000\n(1,655,100,610,838)\n\u3000\n258,180,911,748\xa0\n\xa0 \xa01. 보험금융손익\n(1,657,885,142,329)\n\u3000\n254,571,734,459\xa0\n\u3000\n\xa0 \xa02. 재보험금융손익\n2,784,531,491\xa0\n\u3000\n3,609,177,289\xa0\n\u3000\n\xa0Ⅳ. 영업이익\n\u3000\n761,883,572,444\xa0\n\u3000\n856,679,909,510\xa0\n\xa0Ⅴ. 영업외수익\n33\n\u3000\n5,787,556,677\xa0\n\u3000\n40,719,902,282\xa0\n\xa0VI. 영업외비용\n33\n\u3000\n157,408,439,756\xa0\n\u3000\n178,614,087,417\xa0\n\xa0VII. 법인세비용차감전순이익\n\u3000\n610,262,689,365\xa0\n\u3000\n718,785,724,375\xa0\n\xa0VIII. 법인세비용\n34\n\u3000\n146,778,887,622\xa0\n\u3000\n180,660,314,682\xa0\n\xa0Ⅸ.분기순이익\n\u3000\n463,483,801,743\xa0\n\u3000\n538,125,409,693\xa0\nⅩ. 법인세비용차감후 기타포괄손익\n\u3000\n(818,110,877,743)\n\u3000\n2,881,763,891,668\xa0\n\xa0 \xa01. 후속적으로 당기손익으로 재분류되지 않는 항목\n\u3000\n(48,898,041,843)\n\u3000\n(15,263,653,477)\n\xa0 \xa0 \xa01) 유형자산재평가손익\n(49,216,544,498)\n\u3000\n(11,104,353,132)\n\u3000\n\xa0 \xa0 \xa02) 확정급여채무 재측정요소\n318,502,655\xa0\n\u3000\n(4,159,300,345)\n\u3000\n\xa0 \xa02. 후속적으로 당기손익으로 재분류되는 항목\n\u3000\n(769,212,835,900)\n\u3000\n2,897,027,545,143\xa0\n\xa0 \xa0 \xa01) 기타포괄손익공정가치측정금융자산 평가손익\n1,606,883,284,453\xa0\n\u3000\n-\n\u3000\n\xa0 \xa0 \xa02) \xa0매도가능금융자산평가손익\n-\n\u3000\n\u3000(1,452,262,866,344)\n\u3000\n\xa0 \xa0 \xa03) \xa0만기보유금융자산평가손익\n-\n\u3000\n\u3000-\n\u3000\n\xa0 \xa0 \xa04) \xa0관계·종속기업투자주식평가손익\n4,348,759,445\xa0\n\u3000\n(10,181,232,481)\n\u3000\n\xa0 \xa0 \xa05) \xa0보험계약자산(부채)순금융손익\n(2,552,554,153,843)\n\u3000\n4,547,563,390,770\xa0\n\u3000\n\xa0 \xa0 \xa06) \xa0재보험계약자산(부채)순금융손익\n8,936,952,030\xa0\n\u3000\n(2,185,979,341)\n\u3000\n\xa0 \xa0 \xa07) \xa0위험회피목적파생상품평가손익\n147,860,770,623\xa0\n\u3000\n(191,349,995,005)\n\u3000\n\xa0 \xa0 \xa08) \xa0해외사업환산손익\n15,311,551,392\xa0\n\u3000\n5,444,227,544\xa0\n\u3000\n\xa0XII. 분기총포괄이익(손실)\n\u3000\n(354,627,076,000)\n\u3000\n3,419,889,301,361\xa0\n\xa0XIII. 분기순이익의 귀속\n\u3000\n463,483,801,743\xa0\n\u3000\n538,125,409,693\xa0\n\xa0 \xa01. 지배기업의 소유주\n422,550,182,140\xa0\n\u3000\n478,968,856,480\xa0\n\u3000\n\xa0 \xa02. 비지배지분\n40,933,619,603\xa0\n\u3000\n59,156,553,213\xa0\n\u3000\n\xa0XIV. 주당이익\n\xa0 \xa01. 기본주당이익\n532\n784\n\xa0 \xa02. 희석주당이익\n532\n784\n다. 연결자본변동표\n분 기 연 결 자 본 변 동 표\n제 75기 1분기 : 2023년 1월 1일부터 2023년 03월 31일까지\n제 74 기 1분기 : 2022년 1월 1일부터 202년 03월 31일까지\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 목\n자 \xa0본 \xa0금\n기타불입자본\n신종자본증권\n기타자본구성요소\n이익잉여금\n지배기업의소유주 귀속\n비지배지분\n총 \xa0 \xa0계\n2022년 1월 1일(전기초)\n4,342,650,000,000\n(452,754,777,310)\n2,056,343,999,076\n244,554,628,930\n5,083,054,481,257\n11,273,848,331,954\n2,145,732,682,706\n13,419,581,014,660\n기업회계기준서 제1117호 최초 적용에 따른 조정\n-\n-\n-\n(54,131,569,446)\n2,922,308,668,611\n2,868,177,099,164\n399,978,963\n2,868,577,078,127\n2022년 1월 1일(전기초-조정후)\n4,342,650,000,000\n(452,754,777,310)\n2,056,343,999,076\n190,423,059,484\n8,005,363,149,868\n14,142,025,431,118\n2,146,132,661,669\n16,288,158,092,787\nI. 분기총포괄손익\n-\n-\n-\n-\n-\n-\n-\n-\n1. 분기순이익\n-\n-\n-\n-\n478,873,484,995\n478,873,484,995\n59,156,553,213\n538,030,038,208\n2. 재평가잉여금의 대체\n-\n-\n-\n(14,120,304,511)\n14,120,304,511\n-\n-\n-\n3. 유형자산재평가이익\n-\n-\n-\n4,547,453,436\n4,547,453,436\n-\n4,547,453,436\n4. 순확정급여부채의 재측정요소\n-\n-\n-\n(4,159,300,345)\n-\n(4,159,300,345)\n-\n(4,159,300,345)\n5. 매도가능금융자산평가손익\n-\n-\n-\n(1,326,695,171,570)\n-\n(1,326,695,171,570)\n(300,805,872,269)\n(1,627,501,043,839)\n\xa06. 만기보유금융자산평가손익\n(125,567,694,774)\n-\n(125,567,694,774)\n-\n(125,567,694,774)\n\xa07. 관계기업의 기타포괄손익지분\n-\n-\n-\n(10,181,232,481)\n(10,181,232,481)\n(4,095,435,835)\n(14,276,668,316)\n\xa08. 위험회피목적파생상품평가손익\n-\n-\n-\n(191,349,995,005)\n-\n(191,349,995,005)\n(18,907,711,585)\n(210,257,706,590)\n\xa09. 해외사업환산손익\n-\n-\n-\n4,608,848,104\n-\n4,608,848,104\n835,379,440\n5,444,227,544\n\xa010. 보험계약순금융손익\n-\n-\n-\n4,181,336,689,183\n4,181,336,689,183\n375,799,552,662\n4,557,136,241,845\n\xa011. 재보험계약순금융손익\n-\n-\n-\n(2,118,644,068)\n(2,118,644,068)\n(67,335,273)\n(2,185,979,341)\nII. 자본에 직접 인식된 주주와의 거래\n1. 신종자본증권 배당\n-\n-\n-\n-\n(24,619,289,517)\n(24,619,289,517)\n(3,080,000,000)\n(27,699,289,517)\n2. 주식기준보상\n-\n1,779,008,575\n-\n-\n-\n1,779,008,575\n803,435,224\n2,582,443,799\n3. 비지배지분의 증감\n-\n67,373,003\n-\n-\n-\n67,373,003\n(61,137,960,742)\n(61,070,587,739)\n2022년 3월 31일 (전분기말)\n4,342,650,000,000\n(450,908,395,732)\n2,056,343,999,076\n2,706,723,707,453\n8,473,737,649,857\n17,128,546,960,654\n2,194,633,266,504\n19,323,180,227,158\n2023년 1월 1일(당기초)\n4,342,650,000,000\n3,010,079,475\n1,558,370,079,138\n4,471,921,069,548\n8,440,142,034,324\n18,816,093,262,486\n1,237,715,419,531\n20,053,808,682,017\n기업회계기준서 제1109호 최초 적용에 따른 조정\n-\n-\n-\n(2,452,491,878,339)\n(105,243,088,891)\n(2,557,734,967,231)\n-\n(2,557,734,967,231)\n2023년 1월 1일(당기초-조정후)\n4,342,650,000,000\n3,010,079,475\n1,558,370,079,138\n2,019,429,191,209\n8,334,898,945,433\n16,258,358,295,255\n1,237,715,419,531\n17,496,073,714,786\nI. 분기총포괄손익\n-\n-\n-\n-\n-\n-\n-\n-\n1. 분기순이익\n-\n-\n-\n-\n422,550,182,139\n422,550,182,139\n40,933,619,603\n463,483,801,742\n2. 재평가잉여금의 대체\n-\n-\n-\n-\n-\n-\n-\n-\n3. 유형자산재평가이익\n-\n-\n-\n(49,216,544,498)\n-\n(49,216,544,498)\n-\n(49,216,544,498)\n4. 순확정급여부채의 재측정요소\n-\n-\n-\n318,502,655\n-\n318,502,655\n(229,068,857)\n89,433,798\n5. 기타포괄손익공정가치금융자산평가손익\n-\n-\n-\n1,606,883,284,453\n-\n1,606,883,284,453\n59,711,061,292\n1,666,594,345,745\n6. 관계ㆍ종속기업기타포괄손익지분\n-\n-\n-\n4,348,759,445\n-\n4,348,759,445\n2,655,637,033\n7,004,396,478\n7. 위험회피목적파생상품평가손익\n-\n-\n-\n147,860,770,623\n-\n147,860,770,623\n16,590,703,502\n164,451,474,125\n8. 해외사업환산손익\n-\n-\n-\n15,311,551,392\n-\n15,311,551,392\n1,666,443,360\n16,977,994,752\n9. 보험계약순금융손익\n-\n-\n-\n(2,552,554,153,843)\n-\n(2,552,554,153,843)\n580,969,014,994\n(1,971,585,138,849)\n10. 재보험계약순금융손익\n-\n-\n-\n8,936,952,030\n-\n8,936,952,030\n-\n8,936,952,030\nII. 자본에 직접 인식된 주주와의 거래\n-\n-\n-\n-\n-\n-\n1. 신종자본증권 배당\n-\n-\n-\n-\n(21,284,377,135)\n(21,284,377,135)\n(6,253,750,000)\n(27,538,127,135)\n2. 주식기준 보상\n-\n2,097,617,480\n-\n-\n2,097,617,480\n-\n2,097,617,480\n3. 비지배지분의 증감\n-\n(13,527,405,298)\n-\n(1,914,878,336,667)\n(1,928,405,741,965)\n503,100,779,225\xa0\n(1,425,304,962,740)\n2023년 3월 31일(당분기말)\n4,342,650,000,000\n(8,419,708,343)\n1,558,370,079,138\n1,201,318,313,466\n6,821,286,413,770\n13,915,205,098,031\n2,436,859,859,683\xa0\n16,352,064,957,714\xa0\n라. 연결현금흐름표\n분 기 연 결 현 금 흐 름 표\n제 75기 1분기 : 2023년 1월 1일부터 2023년 03월 31일까지\n제 74 기 1분기 : 2022년 1월 1일부터 2022년 03월 31일까지\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0목\n주 석\n제 75(당) 1분기\n제 74(전) 1분기\nⅠ. 영업활동으로 인한 현금흐름\n\u3000\n2,862,010,955,722\n\u3000\n(342,845,222,723)\n\xa0 \xa0 1. 분기순이익\n463,483,801,742\n\u3000\n538,125,409,693\n\u3000\n\xa0 \xa0 2. 수익ㆍ비용의 조정\n37\n(524,142,749,383)\n\u3000\n(345,323,441,284)\n\u3000\n\xa0 \xa0 3. 영업활동으로 인한 자산ㆍ부채의 변동\n37\n2,485,674,070,713\n\u3000\n(112,443,459,330)\n\u3000\n\xa0 \xa0 4. 이자의 수취\n65,867,364,231\n\u3000\n60,971,512,761\n\u3000\n\xa0 \xa0 5. 이자의 지급\n(272,106,862,723)\n\u3000\n(49,471,081,208)\n\u3000\n\xa0 \xa0 6. 배당금의 수취\n219,453,919,663\n\u3000\n9,812,295,631\n\u3000\n\xa0 \xa0 7. 법인세부담액\n423,781,411,479\n\u3000\n(444,516,458,986)\n\u3000\nⅡ. 투자활동으로 인한 현금흐름\n\u3000\n(4,172,752,830,663)\n\u3000\n(742,528,837,894)\n\xa0 \xa0 1. 매도가능금융자산의 처분\n302,387,375,229\n3,270,042,345,567\n\u3000\n\xa0 \xa0 2. 만기보유금융자산의 상환\n-\n1,500,123,449\n\u3000\n\xa0 \xa0 3. 투자부동산 및 유형자산의 처분\n187,662,682\n147,473,371,042\n\xa0 \xa0 4. 무형자산의 처분\n-\n5,281,744,514\n\xa0 \xa0 5. 관계기업투자의 처분\n76,093,685,760\n13,635,426,786\n\xa0 \xa0 6. 관계기업투자의 배당\n55,946,022,348\n3,870,002,354\n\xa0 \xa0 7. 예치보증금의 감소\n2,354,730,080\n6,893,234,564\n\xa0 \xa0 8. 위험회피목적 파생상품의 정산\n-\n(167,525,421,283)\n\xa0 \xa0 9. 매도가능금융자산의 취득\n-\n(2,240,357,679,071)\n\xa0 \xa0 10. 만기보유금융자산의 취득\n-\n(1,680,895,737,099)\n\xa0 \xa0 11. 기타포괄손익-공정가치측정금융상품의 취득\n(4,505,276,258,712)\n-\n\xa0 \xa0 12. 투자부동산 및 유형자산의 취득\n(37,183,686,212)\n(17,830,863,941)\n\xa0 \xa0 13. 관계기업투자의 취득\n(60,387,995,970)\n(43,356,202,309)\n\xa0 \xa0 14. 무형자산의 취득\n(3,936,645,341)\n(17,726,546,547)\n\xa0 \xa0 15. 예치보증금의 증가\n(1,185,048,770)\n(20,663,935,388)\n\xa0 \xa0 16. 선급금의 증가\n(1,752,671,757)\n(2,868,700,532)\nⅢ. 재무활동으로 인한 현금흐름\n309,443,464,398\n897,421,525,687\n\xa0 \xa0 1. 비지배지분의 감소\n-\n(33,080,000,000)\n\xa0 \xa0 2. 임대보증금 증가\n39,990,041\n9,009,503,556\n\xa0 \xa0 3. 임대보증금 감소\n(159,710,080)\n(5,598,317,969)\n\xa0 \xa0 4. 신종자본증권 배당\n(23,753,164,873)\n(10,340,000,000)\n\xa0 \xa0 5. 차입부채의 감소\n(2,438,780,234,243)\n(2,569,852,400,434)\n\xa0 \xa0 6. 차입부채의 증가\n2,336,984,178,570\n3,272,059,143,916\n\xa0 \xa0 7. 환매조건부채권매도의 순증감\n438,844,600,211\n219,260,972,930\n\xa0 \xa0 8. 기타금융부채의 변동\n39,200,760,586\n39,200,760,586\n\xa0 \xa0 9. 리스부채의 감소\n(42,932,955,814)\n(23,238,136,898)\nⅣ. 현금및현금성자산의 순증가(감소)(Ⅰ+Ⅱ+Ⅲ)\n(1,001,298,410,543)\n(187,952,534,930)\nⅤ. 기초 현금및현금성자산\n2,908,267,355,517\n2,042,936,013,598\nⅥ. 외화표시 현금및현금성자산 환율변동효과\n2,278,448,260\n1,488,728,236\nⅦ. 분기말 현금및현금성자산\n1,909,247,393,234\n1,856,472,206,904\n']"
